KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of GoodwillAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

QuidelOrtho (QDEL) Cash from Financing Activities (2021 - 2025)

Historic Cash from Financing Activities for QuidelOrtho (QDEL) over the last 5 years, with Q3 2025 value amounting to $46.0 million.

  • QuidelOrtho's Cash from Financing Activities rose 27490.49% to $46.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $98.0 million, marking a year-over-year increase of 6360.6%. This contributed to the annual value of $48.8 million for FY2024, which is 11835.97% up from last year.
  • According to the latest figures from Q3 2025, QuidelOrtho's Cash from Financing Activities is $46.0 million, which was up 27490.49% from $103.3 million recorded in Q2 2025.
  • QuidelOrtho's Cash from Financing Activities' 5-year high stood at $424.2 million during Q1 2023, with a 5-year trough of -$99.7 million in Q3 2023.
  • Its 5-year average for Cash from Financing Activities is $26.6 million, with a median of -$11.0 million in 2022.
  • Its Cash from Financing Activities has fluctuated over the past 5 years, first plummeted by 165294.12% in 2023, then surged by 27490.49% in 2025.
  • Quarter analysis of 5 years shows QuidelOrtho's Cash from Financing Activities stood at $1.8 million in 2021, then tumbled by 288.89% to -$3.4 million in 2022, then plummeted by 1600.0% to -$57.8 million in 2023, then decreased by 19.2% to -$68.9 million in 2024, then surged by 166.76% to $46.0 million in 2025.
  • Its Cash from Financing Activities was $46.0 million in Q3 2025, compared to $103.3 million in Q2 2025 and $17.6 million in Q1 2025.